Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alibaba
BABA
|
$812M |
| 2 |
AGN
Allergan plc
AGN
|
$479M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
$344M |
| 4 |
Apple
AAPL
|
$312M |
| 5 |
Meta Platforms (Facebook)
META
|
$264M |
Top Sells
| 1 |
RTX Corp
RTX
|
$839M |
| 2 |
Qualcomm
QCOM
|
$393M |
| 3 |
Las Vegas Sands
LVS
|
$367M |
| 4 |
Perrigo
PRGO
|
$359M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$301M |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Consumer Discretionary | 14.4% |
| 3 | Communication Services | 12.93% |
| 4 | Technology | 11.61% |
| 5 | Energy | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $3.72B | 3.45% | 36,956,507 +3,101,569 | +9% | +$312M |
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $3.09B | 2.87% | 5,301,450 +432,131 | +9% | +$252M |
|
|
3
Meta Platforms (Facebook)
META
$1.86T
| $2.59B | 2.4% | 32,747,920 +3,339,937 | +11% | +$264M |
|
4
Mastercard
MA
$538B
| $2.26B | 2.09% | 30,509,431 -657,540 | -2% | -$48.6M |
|
5
Biogen
BIIB
$19.4B
| $1.92B | 1.78% | 5,807,685 -473,199 | -8% | -$157M |
|
6
Schlumberger
SLB
$55B
| $1.82B | 1.69% | 17,875,053 +724,787 | +4% | +$73.7M |
|
7
Amazon
AMZN
$2.44T
| $1.73B | 1.6% | 5,354,370 -321,767 | -6% | -$104M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $1.56B | 1.45% | 16,507,779 +1,976,980 | +14% | +$187M |
|
9
Nike
NKE
$114B
| $1.46B | 1.35% | 16,352,670 -509,754 | -3% | -$45.5M |
|
10
Gilead Sciences
GILD
$140B
| $1.43B | 1.33% | 13,457,069 -398,940 | -3% | -$42.5M |
|
11
Bristol-Myers Squibb
BMY
$96B
| $1.39B | 1.29% | 27,186,563 +3,511,162 | +15% | +$180M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.39B | 1.29% | 8,383,014 +234,768 | +3% | +$38.9M |
|
13
Booking.com
BKNG
$181B
| $1.37B | 1.27% | 1,182,994 -175,750 | -13% | -$204M |
|
14
Canadian Pacific Kansas City
CP
$69.9B
| $1.37B | 1.27% | 6,584,955 -330,944 | -5% | -$68.7M |
|
15
Boeing
BA
$177B
| $1.36B | 1.26% | 10,696,545 +449,554 | +4% | +$57.3M |
|
16
Novo Nordisk
NVO
$251B
| $1.34B | 1.24% | 28,154,364 +1,259,317 | +5% | +$60M |
|
|
LNKD
17
DELISTED
LinkedIn Corporation
LNKD
| $1.33B | 1.23% | 6,403,179 +456,571 | +8% | +$94.9M |
|
18
Walt Disney
DIS
$213B
| $1.29B | 1.2% | 14,487,704 -495,239 | -3% | -$44.1M |
|
19
Salesforce
CRM
$245B
| $1.23B | 1.14% | 21,443,769 -321,900 | -1% | -$18.5M |
|
20
Visa
V
$683B
| $1.23B | 1.14% | 5,762,651 -164,552 | -3% | -$35.1M |
|
21
Illumina
ILMN
$15.8B
| $1.22B | 1.13% | 7,424,696 -86,160 | -1% | -$14.1M |
|
|
CXO
22
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.18B | 1.09% | 9,401,865 +98,457 | +1% | +$12.3M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $1.17B | 1.09% | 10,448,752 -1,416,257 | -12% | -$159M |
|
24
Merck
MRK
$210B
| $1.17B | 1.08% | 19,659,042 -213,973 | -1% | -$12.7M |
|
|
RHT
25
DELISTED
Red Hat Inc
RHT
| $1.14B | 1.06% | 20,267,573 +1,193,635 | +6% | +$67M |
|